A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.
Related Articles

News
Flipping a Metabolic Switch to Slow Tumor Growth
August 12, 2020
sandiegobiotech
News, UCSD News
Comments Off on Flipping a Metabolic Switch to Slow Tumor Growth
The enzyme serine palmitoyl-transferase can be used as a metabolically responsive “switch” that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Au… […]

News
New Drug Screening Method Answers Why Alzheimer’s Drugs Fail, Suggests New Targets
January 27, 2022
sandiegobiotech
News
Comments Off on New Drug Screening Method Answers Why Alzheimer’s Drugs Fail, Suggests New Targets
A study led by UC San Diego sheds light on why Alzheimer’s drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer’s disease. Click here to view original post… […]

News
Three UC San Diego Engineering Professors Receive Presidential Early Career Awards
July 3, 2019
sandiegobiotech
News
Comments Off on Three UC San Diego Engineering Professors Receive Presidential Early Career Awards